Page last updated: 2024-11-04

suberoyl bis-hydroxamic acid and Carcinoid Tumor

suberoyl bis-hydroxamic acid has been researched along with Carcinoid Tumor in 1 studies

suberoyl bis-hydroxamic acid: antineoplastic, Histone Deacetylase inhibitor

Carcinoid Tumor: A usually small, slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface. The tumor can occur anywhere in the gastrointestinal tract (and in the lungs and other sites); approximately 90% arise in the appendix. It is now established that these tumors are of neuroendocrine origin and derive from a primitive stem cell. (From Stedman, 25th ed & Holland et al., Cancer Medicine, 3d ed, p1182)

Research Excerpts

ExcerptRelevanceReference
"Gastrointestinal and pulmonary carcinoid cells were treated with either VPA or SBHA and lithium chloride for up to 48 hours."5.35Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors. ( Adler, JT; Chen, H; Hottinger, DG; Kunnimalaiyaan, M, 2009)
"Gastrointestinal and pulmonary carcinoid cells were treated with either VPA or SBHA and lithium chloride for up to 48 hours."1.35Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors. ( Adler, JT; Chen, H; Hottinger, DG; Kunnimalaiyaan, M, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adler, JT1
Hottinger, DG1
Kunnimalaiyaan, M1
Chen, H1

Other Studies

1 other study available for suberoyl bis-hydroxamic acid and Carcinoid Tumor

ArticleYear
Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors.
    Annals of surgical oncology, 2009, Volume: 16, Issue:2

    Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Carcinoid

2009